Skip to content

Search

Showing results for "Childhood interstitial lung disease "

Resourceful and creative methods are necessary to research rare disorders

Our investigation used the infrastructure of InterRett, established in 2002 with dual aims of encour- aging international collaboration and ascertaining the...

Privacy protectionism and health information: Is there any redress for harms to health?

Health information collected by governments can be a valuable resource for researchers seeking to improve diagnostics, treatments and public health outcomes.

Off-label use of ondansetron in pregnancy in Western Australia

There is an increasing trend to prescribe ondansetron although its safety for use in pregnancy has not been established.

Jean Golding - A testimonial

A testimonial about Jean Golding's achievements in paediatric epidemiology.

Commentary: Folate and neural tube defects-the influence of Smithells et al. on research and policy in the Antipodes

We wanted to embark on an epidemiological research project that would contribute new knowledge and, at the same time, might prove the value of the registry...

A preliminary study of fetal head circumference growth in Autism Spectrum Disorder

Fetal head circumference (HC) growth was examined prospectively in children with autism spectrum disorder (ASD).

Improving the wellbeing of Australian children and youth: the importance of bridging the know-do gap

Improving the wellbeing of Australian children and youth: the importance of bridging the know-do gap

Interpretation of recent sudden infant death syndrome rates in Western Australia

Data for recent years show a shift away from a classification of 'SIDS' towards a classification of 'unascertainable', particularly for Aboriginal infants.

Precision medicine offering new hope for kids with aggressive cancers

A world-first study involving more than 100 cancer researchers and clinicians across Australia – including from The Kids Research Institute Australia and Perth Children’s Hospital – has shown that precision medicine can significantly improve outcomes for children with high-risk cancer.